1 min read
Add as a preferred source on Google

Nuo Therapeutics Posts $1.9 Million in Q3 Revenue, Up 84.5%

The company’s GAAP loss per share was $0.01 for the quarter.

A blank ivory sheet rises in steps beside a shorter dark block / TokenPost.ai
A blank ivory sheet rises in steps beside a shorter dark block / TokenPost.ai

Nuo Therapeutics (AURX) posted $1.9 million in third-quarter revenue, 84.5% higher than a year earlier. Its GAAP earnings per share was a loss of $0.01.

The revenue figure reflects income from the company’s business activities before expenses. The per-share loss is an earnings measure calculated under generally accepted accounting principles.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…